Metro Healthcare Indonesia Tbk. vs Sarimelati Kencana Tbk. — how do they compare? Metro Healthcare Indonesia Tbk. trades at Rp428 (market cap 14.23T, 346.3K 24h volume), while Sarimelati Kencana Tbk. trades at Rp185 (market cap 553B, 3.72M 24h volume). The key difference: Metro Healthcare Indonesia Tbk. is far larger — about 25.7× Sarimelati Kencana Tbk.'s market cap, and Sarimelati Kencana Tbk. is more actively traded (3.72M versus 346.3K). Which is the better fit depends on your goals.
| CARE | PZZA | |
|---|---|---|
Market Cap | 14.23T | 553B |
Volume | 346.3K | 3.72M |
Lot | 3.46K | 37.22K |
Turnover | 147.93M | 666.16M |
Average Price | 427.18 | 179 |
Value | 147.93M | 666.16M |
Indicative Equilibrium Price | 428 | 185 |
Indicative Equilibrium Volume | 10 | 50 |
Trailing returns across standard periods
Latest headlines on both assets
PT Metro Healthcare Indonesia Tbk (the “Company”) was established under the name PT Aruna Anjaya Perkasa, based on Notarial Deed No. 67 dated October 07, 2015 of Humberg Lie, S.H., S.E., M.Kn notary in Jakarta. The Company started its commercial operations in 2016 .
Read more on CARE →PT Sarimelati Kencana Tbk. (the Company) was established based on Notarial Deed No. 132 dated December 16, 1987 of Lieke Lianadevi Tukgali, S.H.
Read more on PZZA →